Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick Allanore

Showing results (441-450 of 448) with videos related to

Pageof 45
Sort By:
You have reached the last page of results.This site can display upto 448 results.
Rheumatology (Oxford, England)|September 29, 2022
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive diseaseDavid Roofeh, Kevin K Brown, Ella A Kazerooni, et al.
The European Respiratory Journal|July 11, 2020
Methotrexate and rheumatoid arthritis associated interstitial lung diseasePierre-Antoine Juge, Joyce S Lee, Jessica Lau, et al.
Arthritis Care & Research|September 5, 2023
Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?Elisabeth Deibel, Patricia E Carreira, Madelon Vonk, et al.
Autoimmunity Reviews|July 28, 2024
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensusPiero Ruscitti, Yannick Allanore, Chiara Baldini, et al.
Annals of the Rheumatic Diseases|August 25, 2017
Mapping and predicting mortality from systemic sclerosisMuriel Elhai, Christophe Meune, Marouane Boubaya, et al.
The New England Journal of Medicine|October 23, 2018
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung DiseasePierre-Antoine Juge, Joyce S Lee, Esther Ebstein, et al.
Journal of Autoimmunity|April 21, 2026
Beyond screening for pulmonary arterial hypertension: The DETECT score is a potential promising prediction tool for all-cause mortality in systemic sclerosis: Analysis from the EUSTAR databaseFlorian Käs, Muriel Elhai, Mike O Becker, et al.
The Journal of Rheumatology|June 17, 2010
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) databaseJerome Avouac, Ulrich Walker, Alan Tyndall, et al.
Pageof 45

Showing results (441-450 of 448) with videos related to

Sort By:
Pageof 45
You have reached the last page of results.This site can display upto 448 results.
Rheumatology (Oxford, England)|September 29, 2022
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive diseaseDavid Roofeh, Kevin K Brown, Ella A Kazerooni, et al.
The European Respiratory Journal|July 11, 2020
Methotrexate and rheumatoid arthritis associated interstitial lung diseasePierre-Antoine Juge, Joyce S Lee, Jessica Lau, et al.
Arthritis Care & Research|September 5, 2023
Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?Elisabeth Deibel, Patricia E Carreira, Madelon Vonk, et al.
Autoimmunity Reviews|July 28, 2024
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensusPiero Ruscitti, Yannick Allanore, Chiara Baldini, et al.
Annals of the Rheumatic Diseases|August 25, 2017
Mapping and predicting mortality from systemic sclerosisMuriel Elhai, Christophe Meune, Marouane Boubaya, et al.
The New England Journal of Medicine|October 23, 2018
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung DiseasePierre-Antoine Juge, Joyce S Lee, Esther Ebstein, et al.
Journal of Autoimmunity|April 21, 2026
Beyond screening for pulmonary arterial hypertension: The DETECT score is a potential promising prediction tool for all-cause mortality in systemic sclerosis: Analysis from the EUSTAR databaseFlorian Käs, Muriel Elhai, Mike O Becker, et al.
The Journal of Rheumatology|June 17, 2010
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) databaseJerome Avouac, Ulrich Walker, Alan Tyndall, et al.
Pageof 45